Release from Cairo Pharmaceuticals (CPCI.CA) Concerning the Board of Directors & the Executive Managers
Company Name : Cairo Pharmaceuticals
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers
Release from the Company (700 KB)
ISIN Code : EGS38391C016
Reuters Code : CPCI.CA
Content :
Release from the company concerning the Board of Directors & the Executive Managers
Release from the Company (700 KB)
Comments